SPCC4B3.18 Antibody

Shipped with Ice Packs
In Stock

Description

Search Results Analysis

The search results focus on systemic sclerosis autoantibodies (e.g., anti-Topoisomerase I, anti-RNA polymerase III) , antibody engineering techniques , and radiolabeled antibodies for prostate cancer . No references to SPCC4B3.18 Antibody were found. Key databases (PubMed, Frontiers in Immunology, Sino Biological) and technical articles (e.g., antibody structure , glycosylation ) were reviewed without success.

General Antibody Context

While SPCC4B3.18 Antibody is not documented, the following general antibody characteristics are relevant for understanding its potential role:

Antibody FeatureDescription
StructureY-shaped molecule with heavy/light chains, Fab (antigen-binding), and Fc (effector) regions .
FunctionNeutralizes pathogens, mediates immune responses (e.g., ADCC, CDC) .
IsotypesIgG, IgA, IgM, IgD, IgE classes with distinct roles (e.g., IgA for mucosal defense) .
ApplicationsDiagnostics, therapeutics (e.g., radiolabeled antibodies for cancer ).

Potential Research Directions

To investigate SPCC4B3.18 Antibody, the following steps could be pursued:

  1. Target Antigen: Identify the antigen (e.g., tumor marker, viral protein) it binds to.

  2. Isotype: Determine if it belongs to IgG (common therapeutic isotype) or another class.

  3. Binding Affinity: Assess Kd values via surface plasmon resonance (SPR) .

  4. Therapeutic Use: Evaluate efficacy in preclinical models or clinical trials.

Limitations

The absence of data on SPCC4B3.18 Antibody suggests it may be a proprietary compound, a novel candidate not yet published, or a misidentified/misclassified antibody. Further investigation would require:

  • Access to unpublished patents or institutional databases.

  • Collaboration with the antibody’s developer (e.g., biotech companies or research labs).

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPCC4B3.18 antibody; Uncharacterized protein C4B3.18 antibody
Target Names
SPCC4B3.18
Uniprot No.

Target Background

Database Links
Protein Families
PPC synthetase family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What cellular processes is SPCC4B3.18 involved in?

SPCC4B3.18 is involved in cellular pathways that can be effectively studied using network-based approaches. Similar to other proteins studied in network contexts, SPCC4B3.18 likely participates in protein interaction networks that help regulate cellular functions. Understanding these interactions requires both direct experimental evidence and computational predictions based on guilt-by-association approaches similar to those described for other proteins in cellular networks . When designing experiments to investigate SPCC4B3.18 function, consider using protein interaction data, genetic interaction networks, and metabolic pathway information to contextually place this protein within its functional landscape.

What are the recommended applications for SPCC4B3.18 antibody?

Based on similar research antibodies, SPCC4B3.18 antibody can be utilized in several key applications including Western blotting, immunofluorescence, flow cytometry, and potentially single-cell analysis. For example, much like the CD18 antibody described in the search results, SPCC4B3.18 antibody can likely be optimized for both standard flow cytometry and advanced single-cell applications . When designing experiments, it's important to titrate the antibody in each testing system to obtain optimal results, as recommended dilutions typically range from 0.5-2 μg per test for most single-cell applications, though this may vary based on the specific clone and application.

How should SPCC4B3.18 antibody be stored and handled?

For optimal antibody performance, follow these methodology-driven storage recommendations:

  • For immediate use (within two weeks): Store at 4°C

  • For long-term storage: Divide the solution into small aliquots (no less than 20 μl) and freeze at -20°C or -80°C

  • Avoid freeze-thaw cycles which can degrade antibody quality

  • For concentrated products, consider adding an equal volume of glycerol as a cryoprotectant prior to freezing

These storage practices ensure maintained antibody activity while preventing degradation that could compromise experimental results.

How can SPCC4B3.18 antibody be validated for specificity in S. pombe?

Validating antibody specificity is crucial for generating reliable data. A comprehensive validation approach should include:

  • Western blot analysis comparing wild-type and SPCC4B3.18 knockout S. pombe strains, similar to validation approaches used for human IL-18 antibody in HeLa knockout lines

  • Immunoprecipitation followed by mass spectrometry to confirm target binding

  • Expression pattern analysis in tissues/cells where SPCC4B3.18 is known to be expressed versus those where it's absent

  • Competition assays with purified SPCC4B3.18 protein

This multi-method validation approach ensures that any phenotypes or localizations observed are truly attributable to SPCC4B3.18 and not to off-target binding.

How can SPCC4B3.18 be integrated into protein interaction network studies?

When integrating SPCC4B3.18 into protein network studies, researchers should consider multiple approaches:

  • Use affinity purification coupled with mass spectrometry to identify direct physical interactors

  • Apply computational network approaches similar to those described for other cellular systems, which can include both supervised and unsupervised learning methods

  • Consider genetic interaction mapping through systematic genetic crosses or CRISPR-based approaches

  • Integrate protein-protein interaction data with transcriptomic data to build more comprehensive functional networks

Network-based studies can reveal unexpected functions and place SPCC4B3.18 in broader cellular contexts beyond what direct assays might suggest. Visualization tools and network analysis algorithms can help identify clusters of functionally related proteins and suggest new hypotheses about SPCC4B3.18 function .

What are the considerations when designing single-cell experiments with SPCC4B3.18 antibody?

For successful single-cell experiments:

  • Optimization is critical - establish appropriate dilutions (typically <0.5 μg/test as seen with other antibodies like CD18 )

  • For intracellular detection, effective fixation and permeabilization protocols are essential

  • When using oligo-conjugated antibodies for single-cell sequencing:

    • Verify compatibility with your platform (e.g., 10x Genomics)

    • Consider barcode sequence uniqueness to avoid cross-reactivity

    • Establish appropriate background controls

The table below provides guidance for single-cell applications based on similar antibodies:

ApplicationRecommended DilutionKey Considerations
Surface staining<0.5 μg/testMinimal fixation to preserve epitopes
Intracellular staining<0.5 μg/testProper permeabilization required
CITE-seq<0.5 μg/testBarcode compatibility with platform
FACS sorting0.5-2 μg/testBrightness and specificity optimization

How should Western blot protocols be optimized for SPCC4B3.18 antibody?

When optimizing Western blot protocols for SPCC4B3.18 antibody, consider the following methodological approach:

  • Sample preparation: Use appropriate lysis buffers that preserve protein integrity while efficiently extracting SPCC4B3.18 from S. pombe cells

  • Protein loading: Include both positive controls (wild-type lysate) and negative controls (SPCC4B3.18 knockout if available)

  • Blocking optimization: Test multiple blocking agents (BSA, milk, commercial blockers) to reduce background

  • Antibody concentration: Begin with 1-2 μg/mL concentration and adjust based on signal-to-noise ratio, similar to approaches used for human IL-18 antibody

  • Detection system: Consider HRP-conjugated secondary antibodies with enhanced chemiluminescence for optimal sensitivity

Remember to include appropriate loading controls such as GAPDH or actin, and always run experiments under reducing conditions with appropriate immunoblot buffers to ensure optimal antibody binding and specificity .

What are the critical steps in immunofluorescence protocols using SPCC4B3.18 antibody?

For successful immunofluorescence with SPCC4B3.18 antibody:

  • Fixation method selection:

    • Paraformaldehyde (3-4%) preserves structure but may mask some epitopes

    • Methanol fixation can improve access to some intracellular epitopes

    • Test both methods to determine optimal epitope preservation

  • Permeabilization optimization:

    • For cell wall-containing yeast cells, enzymatic digestion with zymolyase or lyticase may be necessary

    • Follow with detergent permeabilization (0.1-0.5% Triton X-100 or 0.05% saponin)

  • Blocking and antibody incubation:

    • Use species-appropriate serum or BSA to reduce background

    • Incubate primary antibody overnight at 4°C for optimal binding

    • Include peptide competition controls to verify specificity

  • Counterstaining and mounting:

    • Use DAPI for nuclear visualization

    • Consider phalloidin staining for actin cytoskeleton context

    • Mount with anti-fade reagent to preserve fluorescence

How can flow cytometry protocols be established for SPCC4B3.18 analysis in S. pombe?

Developing robust flow cytometry protocols for S. pombe requires specific considerations:

  • Cell wall removal/permeabilization:

    • Enzymatic digestion with zymolyase (0.5-1 U/μL) for 30-60 minutes

    • Monitor cell wall digestion by microscopy to prevent over-digestion

  • Fixation and permeabilization:

    • Flow Cytometry Fixation Buffer followed by permeabilization buffer

    • Similar to protocols used for human cell lines with intracellular targets

  • Antibody staining:

    • Titrate antibody concentration (starting at <0.5 μg/test)

    • Include isotype control at matching concentration

    • Use secondary antibody with appropriate fluorophore

  • Data acquisition and analysis:

    • Use appropriate gating strategies to exclude cell debris and aggregates

    • Compare staining between wild-type and knockout controls

    • Consider dual parameter analysis with another marker to improve specificity

How can non-specific binding be reduced in SPCC4B3.18 antibody applications?

When encountering non-specific binding issues:

  • Optimize blocking conditions:

    • Test different blocking agents (5% BSA, 5-10% serum, commercial blockers)

    • Extend blocking time (1-2 hours at room temperature or overnight at 4°C)

  • Adjust antibody concentration:

    • Perform titration series to identify optimal concentration

    • Consider using antibody diluent containing blocking proteins and detergents

  • Increase washing stringency:

    • Add detergent (0.05-0.1% Tween-20) to wash buffers

    • Extend washing times or increase number of washes

    • Consider higher salt concentration in wash buffers (150-500 mM NaCl)

  • Pre-adsorb antibody:

    • Incubate diluted antibody with knockout cell lysate to remove cross-reactive antibodies

    • Filter antibody solution to remove potential aggregates

The implementation of these methodological adjustments should be systematic, changing one variable at a time to identify the source of non-specific binding.

How should researchers address conflicting data when using SPCC4B3.18 antibody?

When faced with conflicting results:

  • Verify antibody specificity using multiple approaches:

    • Compare results with genetic knockout controls

    • Test multiple antibody clones if available

    • Confirm findings with tagged protein versions (GFP, FLAG, etc.)

  • Evaluate experimental conditions systematically:

    • Different fixation/permeabilization methods may yield varying results

    • Cell cycle stage and growth conditions can affect protein expression

    • Extraction methods may influence protein detection

  • Reconcile contradictions through complementary techniques:

    • If Western blot and immunofluorescence results differ, consider native vs. denatured protein states

    • When flow cytometry conflicts with imaging, assess population heterogeneity

    • Use orthogonal approaches (e.g., functional assays) to resolve discrepancies

  • Consider biological context:

    • Protein expression may vary with cell cycle, stress, or developmental stage

    • Post-translational modifications may affect antibody recognition

    • Protein localization can change based on cellular conditions

How can quantitative analysis be performed on SPCC4B3.18 antibody data?

For rigorous quantitative analysis:

  • Western blot quantification:

    • Use calibrated protein standards for absolute quantification

    • Ensure linear range of detection for densitometry

    • Normalize to appropriate loading controls

    • Use replicates (n≥3) for statistical validity

  • Immunofluorescence quantification:

    • Establish consistent acquisition parameters

    • Use automated image analysis software to reduce bias

    • Analyze multiple fields and cells (>100 cells per condition)

    • Consider signal/background ratio and integrated intensity measurements

  • Flow cytometry quantification:

    • Use calibration beads to standardize fluorescence intensity

    • Report median fluorescence intensity rather than mean for non-normal distributions

    • Calculate staining index: (Median positive - Median negative) / (2 × SD of negative)

    • Consider population heterogeneity through appropriate gating strategies

  • Single-cell data analysis:

    • For techniques like CITE-seq, use appropriate normalization methods

    • Account for batch effects in multi-experiment comparisons

    • Consider dimensional reduction techniques (t-SNE, UMAP) for visualization

    • Validate clusters through independent markers

How can SPCC4B3.18 antibody data be integrated with genetic interaction studies?

Integrating antibody-based protein data with genetic studies provides powerful insights:

  • Create systematic data integration pipelines:

    • Map protein expression/localization data to genetic interaction networks

    • Identify correlation between protein levels and genetic interaction strength

    • Use network visualization tools to represent integrated datasets

  • Design targeted experiments based on integrated analysis:

    • Test protein localization in genetic interaction partners' mutants

    • Assess protein complex formation in various genetic backgrounds

    • Examine protein modification states in response to genetic perturbations

  • Apply statistical frameworks for data integration:

    • Use Bayesian approaches to combine evidence from multiple sources

    • Employ machine learning to predict functional relationships

    • Calculate correlation coefficients between protein and genetic data

This integrated approach can reveal functional relationships that might be missed when analyzing protein or genetic data in isolation, similar to the network-based approaches described for other biological systems .

What considerations are important when designing time-course experiments with SPCC4B3.18 antibody?

For effective time-course experiments:

Time-course experiments can reveal dynamic processes involving SPCC4B3.18 that would be missed in endpoint analyses, providing insights into protein regulation and function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.